Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9586 | 1074 | 42.9 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LRRK2 | Author keyword | 460 | 77% | 29% | 310 |
2 | LEUCINE RICH REPEAT KINASE 2 | Author keyword | 111 | 86% | 5% | 56 |
3 | PARK8 | Author keyword | 93 | 91% | 4% | 39 |
4 | LEUCINE RICH REPEAT KINASE 2 LRRK2 | Author keyword | 85 | 85% | 4% | 45 |
5 | G2019S | Author keyword | 46 | 82% | 3% | 27 |
6 | DARDARIN | Author keyword | 34 | 79% | 2% | 22 |
7 | G2019S MUTATION | Author keyword | 27 | 92% | 1% | 11 |
8 | LRRK2 GENE | Author keyword | 21 | 85% | 1% | 11 |
9 | CELL BIOL GENE EXP S UNIT | Address | 12 | 52% | 2% | 17 |
10 | LRRK1 | Author keyword | 12 | 86% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LRRK2 | 460 | 77% | 29% | 310 | Search LRRK2 | Search LRRK2 |
2 | LEUCINE RICH REPEAT KINASE 2 | 111 | 86% | 5% | 56 | Search LEUCINE+RICH+REPEAT+KINASE+2 | Search LEUCINE+RICH+REPEAT+KINASE+2 |
3 | PARK8 | 93 | 91% | 4% | 39 | Search PARK8 | Search PARK8 |
4 | LEUCINE RICH REPEAT KINASE 2 LRRK2 | 85 | 85% | 4% | 45 | Search LEUCINE+RICH+REPEAT+KINASE+2+LRRK2 | Search LEUCINE+RICH+REPEAT+KINASE+2+LRRK2 |
5 | G2019S | 46 | 82% | 3% | 27 | Search G2019S | Search G2019S |
6 | DARDARIN | 34 | 79% | 2% | 22 | Search DARDARIN | Search DARDARIN |
7 | G2019S MUTATION | 27 | 92% | 1% | 11 | Search G2019S+MUTATION | Search G2019S+MUTATION |
8 | LRRK2 GENE | 21 | 85% | 1% | 11 | Search LRRK2+GENE | Search LRRK2+GENE |
9 | LRRK1 | 12 | 86% | 1% | 6 | Search LRRK1 | Search LRRK1 |
10 | EIF4G1 | 11 | 69% | 1% | 9 | Search EIF4G1 | Search EIF4G1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEURONAL TOXICITY | 330 | 96% | 9% | 101 |
2 | LEUCINE RICH REPEAT KINASE 2 LRRK2 | 210 | 97% | 6% | 61 |
3 | ROC DOMAIN | 167 | 100% | 4% | 44 |
4 | AUTOSOMAL DOMINANT PARKINSONISM | 155 | 53% | 19% | 204 |
5 | LEUCINE RICH REPEAT KINASE 2 | 149 | 98% | 4% | 40 |
6 | G2019S | 139 | 79% | 8% | 88 |
7 | REPEAT KINASE 2 | 129 | 78% | 8% | 85 |
8 | DISEASE ASSOCIATED MUTATIONS | 124 | 71% | 9% | 101 |
9 | G2019S MUTATION | 115 | 83% | 6% | 66 |
10 | GENE LRRK2 | 106 | 100% | 3% | 31 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The Genetics of Parkinson's Disease: Progress and Therapeutic Implications | 2013 | 75 | 78 | 42% |
LRRK2 and neuroinflammation: partners in crime in Parkinson's disease? | 2014 | 14 | 115 | 57% |
LRRK2 and Parkinson Disease | 2010 | 58 | 64 | 88% |
Mechanisms of LRRK2-Mediated Neurodegeneration | 2012 | 21 | 86 | 95% |
Parkinson's disease: from monogenic forms to genetic susceptibility factors | 2009 | 273 | 149 | 38% |
Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease? | 2012 | 21 | 70 | 90% |
Progress in unraveling the genetic etiology of Parkinson disease in a genomic era | 2015 | 4 | 118 | 26% |
A visual review of the interactome of LRRK2: Using deep-curated molecular interaction data to represent biology | 2015 | 2 | 72 | 46% |
Small Molecule Kinase Inhibitors for LRRK2 and Their Application to Parkinson's Disease Models | 2012 | 22 | 74 | 84% |
Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's disease | 2012 | 25 | 79 | 77% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CELL BIOL GENE EXP S UNIT | 12 | 52% | 1.6% | 17 |
2 | WANGJIANG HOSP | 7 | 56% | 0.8% | 9 |
3 | RD CELL DESIGN | 6 | 80% | 0.4% | 4 |
4 | REGENERAT MED CELL DESIGN | 6 | 80% | 0.4% | 4 |
5 | BOOTH GARDNER PARKINSONS CARE | 6 | 44% | 1.0% | 11 |
6 | NEUROBIOL GENE THER Y | 5 | 22% | 2.0% | 22 |
7 | NEUROREGENERAT PROGRAM | 5 | 27% | 1.4% | 15 |
8 | PL NEUROGENET | 4 | 42% | 0.7% | 8 |
9 | CELL BIOL GENE EXP S SECT | 4 | 38% | 0.7% | 8 |
10 | TRANSGEN SECT | 4 | 41% | 0.7% | 7 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000290955 | PARKIN//PINK1//AUTOSOMAL RECESSIVE JUVENILE PARKINSONISM |
2 | 0.0000130047 | ALPHA SYNUCLEIN//SYNUCLEIN//BETA SYNUCLEIN |
3 | 0.0000116810 | CUERPO NEUROQUIM//NEUROREGENERAT GRP//TEAM ANIM OURCES |
4 | 0.0000095809 | RETROMER//SORTING NEXIN//VPS35 |
5 | 0.0000084470 | MOL CELLULAR TOXICOL HUMAN PLICAT//OULU CITY HOSP//DOOR TO DOOR SURVEYS |
6 | 0.0000076459 | DJ 1//PARK7//DJ 1 PARK7 |
7 | 0.0000060173 | PKAN//HALLERVORDEN SPATZ SYNDROME//NBIA |
8 | 0.0000058252 | NEUROPHARMACOL SECT//NEUROANAT EXPT NEUROL//PHARMACOL CHEM |
9 | 0.0000046439 | TRANSCRANIAL SONOGRAPHY//SUBSTANTIA NIGRA HYPERECHOGENICITY//BRAIN PARENCHYMA SONOGRAPHY |
10 | 0.0000039546 | PARKINSONS DISEASE DEMENTIA//MOTOR SUBTYPE//SECT PARKINSON DIS MOVEMENT DISORDERS |